Back to Dashboard
REGN · Unknown

REGENERON PHARMACEUTICALS

USA Unknown Filing: 2025-12-31
9
Tracked Holders
Limited info. REGENERON PHARMACEUTICALS is not currently in our model portfolio, but 9 tracked investors hold it. We're showing what we know from their latest 13F filings.
9
Investors
0
New positions
4
Increasing
5
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
Increased +15%
% of portfolio
5.7%
Position change
+15%
5.7% of Southeastern Asset Mgmt's portfolio
Trust weight: 1.0×
Increased +38%
% of portfolio
0.4%
Position change
+38%
0.4% of AQR Capital Management's portfolio
Trust weight: 1.1×
Increased +30%
% of portfolio
0.3%
Position change
+30%
0.3% of Point72's portfolio
Trust weight: 1.0×
Increased +89%
% of portfolio
0.2%
Position change
+89%
0.2% of Millennium Management's portfolio
Trust weight: 1.1×
Decreased −5%
% of portfolio
0.2%
Position change
−5%
0.2% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
Decreased −69%
% of portfolio
0.2%
Position change
−69%
0.2% of Bridgewater Associates's portfolio
Trust weight: 1.0×
Decreased −82%
% of portfolio
0.1%
Position change
−82%
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
Decreased −37%
% of portfolio
0.1%
Position change
−37%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.3×
Decreased −99%
% of portfolio
0.0%
Position change
−99%
0.0% of ARK Invest's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to REGENERON PHARMACEUTICALS
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell REGENERON PHARMACEUTICALS or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime